Back to Search
HERBERT DUVIVIER, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1710982731IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
0101281298(VA)75658(MN)277161(NY)
Education
TUFTS UNIVERSITY SCHOOL OF MEDICINE
Class of 1988
Research & Publications (4)
Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen.
PMID 19226361·Eur J Haematol·2009
3-trial
A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.
PMID 19188182·Clin Cancer Res·2009
3-trial
Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss.
PMID 18829511·Clin Cancer Res·2008
3-trial
Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood.
PMID 16312231·J Vet Diagn Invest·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3085 HARLEM RD STE 300
CHEEKTOWAGA, NY 14225 - Phone
- (716) 442-5422
Quick Facts
- NPI
- 1710982731
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 38
- Publications
- 4
Are you this provider?
Claim Your Profile